[Pathophysiological and toxicological aspects of Schistosoma mansoni infection in Mastomys natalensis under treatment with Hycanthone].
D000410:Alanine Transaminase / Q000097:blood; D000818:Animals; D001219:Aspartate Aminotransferases / Q000097:blood; D004195:Disease Models, Animal; D005260:Female; D005969:Glutamate Dehydrogenase / Q000097:blood; D007770:L-Lactate Dehydrogenase / Q000097:blood; D008107:Liver Diseases / Q000503:physiopathology; D008297:Male; D008698:Mesylates / Q000627:therapeutic use / Q000633:toxicity*; D051379:Mice; D008815:Mice, Inbred Strains; D010088:Oxidoreductases / Q000097:blood; D010270:Parasite Egg Count; D012547:Schistosoma / Q000201:enzymology*; D012552:Schistosomiasis / Q000188:drug therapy / Q000201:enzymology / Q000503:physiopathology*; D013012:Sorbitol / Q000097:blood; D014966:Xanthenes / Q000627:therapeutic use / Q000633:toxicity*
D008698:Mesylates; D014966:Xanthenes; D013012:Sorbitol; D010088:Oxidoreductases; D007770:L-Lactate Dehydrogenase; D005969:Glutamate Dehydrogenase; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase
Pathophysiologische und toxikologische Aspekte bei der Schistosoma mansoni-Infektion der Mastomys natalensis unter der Chemotherapie mit Hycanthone.